Concepedia
6
Publications
280
Citations
H-Index
2017
Active since
Affiliations
Erasmus MC(Current)
Erasmus University Rotterdam
University of Groningen
University Medical Center Groningen
University Medical Center Utrecht
Ingeborg E A Wijting is an author at Erasmus MC specializing in clinical trials, medicine, and hiv.
Top concepts
HivMedicineClinical Trials
Publications per year
2017–2019
Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial
Ingeborg E A Wijting, Casper Rokx, Charles A. Boucher et al. · The Lancet HIV · 2017 · 110 citations · Full text
Maintenance Monotherapy, Treatment And Prevention, Human Retrovirus +7
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy
Ingeborg E A Wijting, Cynthia Lungu, Bart Rijnders et al. · The Journal of Infectious Diseases · 2018 · 78 citations · Full text
The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors
Hanh Thi Pham, Lydia Labrie, Ingeborg E A Wijting et al. · The Journal of Infectious Diseases · 2018 · 40 citations · Full text
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy
Ingeborg E A Wijting, Ferdinand W.N.M. Wit, Casper Rokx et al. · EClinicalMedicine · 2019 · 30 citations · Full text
Urinary tract infections in a university hospital: pathogens and antibiotic susceptibility.
Ingeborg E A Wijting, Jelmer Alsma, Damian C. Melles∗ et al. · PubMed · 2019 · 11 citations
Rows per page
1–5 of 6